Previous Close | 1.4300 |
Open | 1.4300 |
Bid | 1.4500 x 2200 |
Ask | 0.0000 x 900 |
Day's Range | 1.4300 - 1.5499 |
52 Week Range | 1.3500 - 10.9400 |
Volume | |
Avg. Volume | 1,029,334 |
Market Cap | 72.401M |
Beta (5Y Monthly) | -0.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NATICK, Mass., May 30, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support patients prescribed GLP-1s and other anti-obesity medications and the first commercial agreements for its Virtual Care Suite (VCS) in the United States. With this update to Coach Iris, patients now have access to 24/7 personalized coaching and guidance specific to GLP-1s an
NATICK, Mass., May 29, 2024--Allurion to Participate in Two Upcoming Investor Conferences in June 2024
NATICK, Mass., May 15, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European Congress on Obesity (ECO) held in Venice, Italy, on 12-15 May, 2024.